BAP1,PBRM1andSETD2in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BAP1,PBRM1andSETD2in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 15, Issue 9, Pages 1201-1210
Publisher
Informa UK Limited
Online
2015-07-11
DOI
10.1586/14737159.2015.1068122
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular pathways in renal cell carcinoma
- (2015) Daniel Su et al. CURRENT OPINION IN ONCOLOGY
- BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells
- (2015) Hui Pan et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- BAP1 Has a Survival Role in Cutaneous Melanoma
- (2015) Raj Kumar et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Loss of PBRM1 and BAP1 expression is less common in non–clear cell renal cell carcinoma than in clear cell renal cell carcinoma
- (2015) Thai H. Ho et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Inference on germlineBAP1mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area
- (2014) Marta Betti et al. GENES CHROMOSOMES & CANCER
- Molecular Genetics of Clear-Cell Renal Cell Carcinoma
- (2014) James Brugarolas JOURNAL OF CLINICAL ONCOLOGY
- Requirement for PBAF in Transcriptional Repression and Repair at DNA Breaks in Actively Transcribed Regions of Chromatin
- (2014) Andreas Kakarougkas et al. MOLECULAR CELL
- Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
- (2014) Steffen Durinck et al. NATURE GENETICS
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- Bap1is essential for kidney function and cooperates withVhlin renal tumorigenesis
- (2014) Shan-Shan Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SETD2-Dependent Histone H3K36 Trimethylation Is Required for Homologous Recombination Repair and Genome Stability
- (2014) Sophia X. Pfister et al. Cell Reports
- BAF180 Promotes Cohesion and Prevents Genome Instability and Aneuploidy
- (2014) Peter M. Brownlee et al. Cell Reports
- SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint
- (2014) Sílvia Carvalho et al. eLife
- Germline BAP1 Mutations Predispose to Renal Cell Carcinomas
- (2013) Tatiana Popova et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma
- (2013) Richard W. Joseph et al. CANCER
- Cooperation and Antagonism among Cancer Genes: The Renal Cancer Paradigm
- (2013) S. Pena-Llopis et al. CANCER RESEARCH
- Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials
- (2013) Roberto Iacovelli et al. CANCER TREATMENT REVIEWS
- The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutSα
- (2013) Feng Li et al. CELL
- Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network
- (2013) A. A. Hakimi et al. CLINICAL CANCER RESEARCH
- Aberrant promoter hypermethylation ofPBRM1,BAP1,SETD2,KDM6Aand other chromatin-modifying genes is absent or rare in clear cell RCC
- (2013) Ilsiya Ibragimova et al. Epigenetics
- BAP1 is phosphorylated at serine 592 in S-phase following DNA damage
- (2013) Ziad M. Eletr et al. FEBS LETTERS
- Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects
- (2013) J. M. Simon et al. GENOME RESEARCH
- Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
- (2013) Payal Kapur et al. LANCET ONCOLOGY
- A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma
- (2013) M. N. Farley et al. MOLECULAR CANCER RESEARCH
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- Alterations in chromatin accessibility and DNA methylation in clear cell renal cell carcinoma
- (2013) M J Buck et al. ONCOGENE
- Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair
- (2013) H. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations between CT Imaging Features and Mutations
- (2013) Christoph A. Karlo et al. RADIOLOGY
- Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma
- (2012) A. Ari Hakimi et al. EUROPEAN UROLOGY
- Loss of PBRM1 expression is associated with renal cell carcinoma progression
- (2012) Rafal Pawłowski et al. INTERNATIONAL JOURNAL OF CANCER
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
- (2012) Jinghui Zhang et al. NATURE
- BAP1 loss defines a new class of renal cell carcinoma
- (2012) Samuel Peña-Llopis et al. NATURE GENETICS
- Prevalence of germlineBAP1mutation in a population-based sample of uveal melanoma cases
- (2012) Lauren G. Aoude et al. Pigment Cell & Melanoma Research
- Evolutionary Constraint Helps Unmask a Splicing Regulatory Region in BRCA1 Exon 11
- (2012) Michela Raponi et al. PLoS One
- Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families
- (2012) Ching-Ni Jenny Njauw et al. PLoS One
- Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer
- (2012) A. H. Shain et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma
- (2011) John D. Hainsworth et al. CANCER INVESTIGATION
- Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma
- (2011) S. Landreville et al. CLINICAL CANCER RESEARCH
- SpliceAid 2: A database of human splicing factors expression data and RNA target motifs
- (2011) Francesco Piva et al. HUMAN MUTATION
- Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers
- (2011) M. H. Abdel-Rahman et al. JOURNAL OF MEDICAL GENETICS
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- (2011) Brian I Rini et al. LANCET
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
- (2011) Ignacio Varela et al. NATURE
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
- (2011) Matthew Bott et al. NATURE GENETICS
- Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma
- (2011) Guangwu Guo et al. NATURE GENETICS
- Germline BAP1 mutations predispose to malignant mesothelioma
- (2011) Joseph R Testa et al. NATURE GENETICS
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence
- (2010) A. E. Burrows et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
- (2010) J. W. Harbour et al. SCIENCE
- The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters
- (2009) W Al Sarakbi et al. BMC CANCER
- BAF180 Is a Critical Regulator of p21 Induction and a Tumor Suppressor Mutated in Breast Cancer
- (2008) W. Xia et al. CANCER RESEARCH
- BRCA1-Associated Protein 1 Interferes with BRCA1/BARD1 RING Heterodimer Activity
- (2008) H. Nishikawa et al. CANCER RESEARCH
- Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400
- (2008) Arthur P. Young et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now